BIOTON S.A. (WSE:BIO)
Poland · Delayed Price · Currency is PLN 3.610
+0.110 (3.14%)
Sep 25, 2026, 11:54 AM CET
BIOTON Market Cap
BIOTON has a market cap or net worth of 300.52 million as of September 24, 2026. Its market cap has decreased by -22.22% in one year.
Market Cap
300.52M
Enterprise Value
366.53M
Revenue
257.23M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.61
ChartMarket Cap Chart
Since July 1, 2005, BIOTON's market cap has decreased from 1.09B to 300.52M, a decrease of -72.51%. That is a compound annual growth rate of -5.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 300.52M | -9.33% |
| Dec 30, 2025 | 331.44M | 33.80% |
| Dec 30, 2024 | 247.72M | -19.19% |
| Dec 29, 2023 | 306.54M | 5.93% |
| Dec 30, 2022 | 289.36M | -19.47% |
| Dec 30, 2021 | 359.34M | -2.21% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Syn2bio | 605.80M |
| Captor Therapeutics Spolka Akcyjna | 443.47M |
| Bioceltix | 413.81M |
| Ryvu Therapeutics | 368.07M |
| Synthaverse | 217.46M |
| Molecure | 148.75M |
| Mabion | 125.74M |
| Poltreg | 122.47M |